Serious Hernia Mesh Complications: Why Thousands of Patients Are Pursuing Legal Action in 2026

Over the past decade, hernia mesh litigation has become one of the most active areas of medical device law in the United States. As we continue our prior reporting on the epidemic of complications tied to polypropylene-based mesh implants, it is clear that the devices used in hernia repair — many of which share design elements with transvaginal mesh — are causing devastating long-term injuries. Patients who underwent seemingly routine procedures are now facing chronic pain, mesh erosion into organs, recurrent hernias, and life-threatening infections years after the original surgery. This is not a historical footnote; it is an ongoing public health crisis that has forced the FDA to revisit its 510(k) clearance pathway and compelled thousands of plaintiffs to join mass tort litigation.

With that context, let us examine the specific failures that have triggered the largest hernia mesh MDLs in history and explain what your legal options are if you or a loved one is suffering from a mesh-related adverse event.

Physiomesh and C-Qur Recalls: Lessons from the Class Action MDL 2782

The FDA never required premarket clinical trials for most hernia mesh devices, allowing them onto the market under the controversial 510(k) process. Two of the most heavily litigated examples are Ethicon’s Physiomesh and Atrium Medical’s C-Qur. Both were voluntarily recalled after thousands of adverse event reports surfaced — but not before they had been implanted in hundreds of thousands of patients. By 2019, the federal judiciary consolidated Physiomesh lawsuits into MDL 2782 (Northern District of Georgia), and a subsequent class action was certified in Canada. While some manufacturers have reached partial settlement agreements, many cases remain active as new testing data reveals that certain “lightweight” meshes degrade in vivo far earlier than claimed.

The table above is not exhaustive; dozens of devices remain on the market despite accumulating evidence of failure. Litigation against Ethicon, Atrium, and Bard has already resulted in multi-million-dollar verdicts for plaintiffs, but manufacturers continue to defend their products vigorously, making individual trials costly and slow.

“We are currently speaking with hernia patients across the country who are claiming that the mesh caused them to suffer serious complications including chronic pain, infections, adhesions, and blockages. Some of these patients are accusing the mesh manufacturers of failing to perform adequate testing and misrepresenting the safety of their mesh devices.” — from our 2025 investigative series, MeshInjury.org and archived case data.

Chronic Pain, Adhesions, and Mesh Erosion: The Medical Reality Behind Adverse Events

The most severe complications do not appear immediately. As we have documented, polypropylene mesh contracts over time, causing erosion into the bowel or bladder in a process called “mesh ingrowth.” This can occur three, five, or even ten years post-implantation. Patients often attribute their symptoms to aging or other medical conditions, unaware that the mesh—often a permanent synthetic scaffold—is the root cause. The list of recognized adverse events includes:

• Chronic debilitating pain at the implant site, often requiring opioid therapy
• Intestinal adhesions leading to bowel obstruction, fistulas, or perforation
• Recurrent hernias that require revision surgery with even more complex hardware
• Serious infections such as methicillin-resistant Staphylococcus aureus (MRSA) seeding on the mesh
• Mesh migration into the scrotum, abdominal wall, or thoracic cavity

These conditions often demand open surgical removal (explanation), which carries its own risks of bowel resection, nerve damage, and permanent disability. The FDA has acknowledged that “the rate of surgical revision for mesh-related complications may be as high as 10-20%” in some patient populations, a figure that many surgeons believe is underreported due to lack of centralized tracking.

Your Legal Rights After a Hernia Mesh Implant: Statute of Limitations and Mass Tort Updates

Every state imposes a statute of limitations on product liability claims, typically ranging from two to six years from the date of injury or discovery. In hernia mesh cases, the “discovery rule” often applies, meaning the clock starts ticking when you reasonably should have known that your complications were caused by the device — not the date of the original surgery. This is critical because many patients are only now connecting their chronic pain to the mesh, years later. Filing deadlines are strict, and missing them can bar recovery entirely.

Currently, the largest active mass tort is MDL 2846 (In re: Davol, Inc. / C.R. Bard, Inc. Polypropylene Hernia Mesh Products Liability Litigation), with over 20,000 pending cases in the Southern District of Ohio. Ethicon’s Physiomesh class action (MDL 2782) has seen partial settlements, but new cases continue to be filed. If you are considering litigation, you need experienced counsel who understands the science of mesh degradation and the specific discovery orders in these MDLs.

The path forward is clear: document your symptoms, gather your operative notes and implant records, and consult with a legal firm that handles mass tort cases. Compensation for past and future medical expenses, lost wages, pain and suffering, and loss of consortium may be available. Do not wait until the statute of limitations runs out.

If you have suffered chronic pain, infection, or required revision surgery after a hernia mesh implant, we urge you to request a claim assessment today. Our team will review your case free of charge and connect you with a qualified hernia mesh plaintiff attorney who can help you navigate the settlement process or prepare for trial. Every day you delay may jeopardize your right to compensation.